CAS 918311-87-2

UCL 2077

CAS : 918311-87-2

Formule : C₂₅H₂₂N₂

Degré de pureté : 96%

Couleur et forme : Solid

Masse moléculaire : 350.4556

Ref: IN-DA006GG1

UCL 2077

CAS : 918311-87-2

UCL 2077

Degré de pureté : ≥98%

Masse moléculaire : 350.46g/mol

Ref: 54-BUP15294

UCL 2077

CAS : 918311-87-2

Formule : C₂₅H₂₂N₂

Masse moléculaire : 350.46

Ref: 7W-GL6592

UCL 2077

CAS : 918311-87-2

UCL 2077 is a small-molecule drug that has been shown to inhibit the production of cytosolic calcium in cancer cells. It also has antineoplastic properties, which may be due to its ability to inhibit the proliferation of cancer cells. UCL 2077 binds to the calcium binding site on the hippocalcin protein, which regulates intracellular calcium levels. This interaction inhibits the function of this protein and inhibits cell growth by reducing intracellular calcium levels.

Formule : C₂₅H₂₂N₂

Degré de pureté : Min. 95%

Masse moléculaire : 350.46 g/mol

Ref: 3D-TLB31187

UCL 2077

CAS : 918311-87-2

UCL 2077 blocks KCNQ channels, related to epilepsy, and selective slow-afterhyperpolarization channels, with 500 nM IC50, sparing Ca2+ channels.

Formule : C₂₅H₂₂N₂

Degré de pureté : 99.58%

Couleur et forme : Solid

Masse moléculaire : 350.46

Ref: TM-T17197